FBXO5 and gastric adenocarcinoma: Notably, highly expressed FBXO5 in STAD (stomach adenocarcinoma) was a protective factor for DFI and PFI survival, and this was different from most cancers in which increased FBXO5 acted as an unfavorable prognostic factor, implying that FBXO5 may have specific functions in STAD.